Inmune Bio Stock Options Expiring on 17th of March 2023

INMB
 Stock
  

USD 7.06  0.01  0.14%   

Inmune Bio's latest option contracts expiring on 2023-03-17 are carrying combined implied volatility of 86.49 with a put-to-call open interest ratio of 0.0 over 16 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2023-03-17. The current put volume is at 104, with calls trading at the volume of 151. This yields a 0.69 put-to-call volume ratio. The Inmune Bio option chain provides detailed quote and price information for the current Inmune Bio option contracts. It shows all of Inmune Bio's listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows Inmune Bio's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Inmune Bio's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Inmune Bio's option, there is no secondary market available for investors to trade.

Inmune Bio Maximum Pain Price across 2023-03-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Inmune Bio close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Inmune Bio's stock options are financial instruments that give investors the right to buy or sell shares of Inmune Bio common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Inmune stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Inmune Bio's stock price goes up or down, the stock options follow.
Please see Risk vs Return Analysis.
Please note that buying 'in-the-money' options on Inmune Bio lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Inmune Bio's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Inmune Bio contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Inmune Stock moves the wrong way.
As of November 27, 2022, Net Income Common Stock is expected to decline to about (31.1 M)

Inmune Bio In The Money Call Balance

When Inmune Bio's strike price is surpassing the current stock price, the option contract against Inmune Bio stock is said to be in the money. When it comes to buying Inmune Bio's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Inmune Bio are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Inmune Current Options Market Mood

Inmune Bio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Inmune Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most options investors, including buyers and sellers of Inmune Bio's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Inmune Bio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Inmune Bio's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Inmune contract

Base on the Rule 16, the options market is currently suggesting that Inmune Bio will have an average daily up or down price movement of about 5.41% per day over the life of the 2023-03-17 option contract. With Inmune Bio trading at $7.06, that is roughly $0.38. If you think that the market is fully incorporating Inmune Bio's daily price movement you should consider buying Inmune Bio options at the current volatility level of 86.49%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Inmune Bio Option Chain

When Inmune Bio's strike price is surpassing the current stock price, the option contract against Inmune Bio stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2022-12-162023-01-202023-03-172023-06-16
Inmune Bio's option chain is a display of a range of information that helps investors for ways to trade options on Inmune. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Inmune. It also shows strike prices and maturity days for a Inmune Bio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2023-03-17 CALL at $2.50.94760.016902023-03-174.2 - 5.40.0In
Call
2023-03-17 CALL at $5.00.81440.062402023-03-172.15 - 3.32.5In
Call
2023-03-17 CALL at $7.50.55570.117302023-03-170.9 - 1.51.15Out
Call
2023-03-17 CALL at $10.00.31930.106802023-03-170.5 - 1.050.55Out
Call
2023-03-17 CALL at $15.00.18010.061202023-03-170.05 - 0.60.14Out
 Put
2023-03-17 PUT at $5.0-0.16710.071502023-03-170.05 - 0.750.45Out
 Put
2023-03-17 PUT at $7.5-0.44590.116202023-03-171.2 - 1.951.6In
 Put
2023-03-17 PUT at $10.0-0.59130.088402023-03-171.7 - 3.83.06In
 Put
2023-03-17 PUT at $12.5-0.90370.062102023-03-174.0 - 7.00.0In
 Put
2023-03-17 PUT at $15.0-0.97060.021602023-03-177.4 - 8.50.0In
 Put
2023-03-17 PUT at $17.5-0.79210.053802023-03-179.9 - 10.80.0In
 Put
2023-03-17 PUT at $20.0-0.80010.048102023-03-1712.4 - 13.30.0In

Inmune Bio Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
   Net Income Common Stock   
Share
       Timeline  

Inmune Bio Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Inmune Bio, understanding its historical liability is critical in projecting Inmune Bio's future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Inmune Bio uses its financing power over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Inmune Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Inmune Bio using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
126.7 M
Quarterly Revenue Growth YOY
6.0
Return On Assets
(0.19) 
Return On Equity
(0.41) 
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.